Health
VC Speaks on U.S. Investment Restrictions in China
A prominent venture capitalist argues against federal restrictions on investment in China’s drug industry, suggesting such measures could harm innovation.
Coverage timeline — 1 article
STAT News
Should the federal government try to slow — or even block — U.S. biotech deals that could benefit China?
2026-06-17 08:30 UTC